超级碰在线-超级碰碰永久免费视频播放-超级碰碰碰免费视频播放-超级碰碰碰免费视频-亚洲国产99在线精品一区69堂-亚洲高清资源在线观看

北京依格斯Excel PharmaStudies
依格斯(北京)醫療科技有限公司成立于1999年，是中國最早的臨床研究合同研究組織(CRO)公司之一。作為中國領先的CRO，依格斯提供與藥品臨床開發相關的一系列專業服務，包括產品注冊、一期至四期臨床試驗、生物等效性試驗和國際多中心臨床試驗的監查、項目管理、受試者招募、數據管理、生物統計、翻譯、醫學報告撰寫、市場調研和產品開發戰略咨詢等。

公司總部位于北京，在上海、廣州、南京、成都、重慶、沈陽、南寧、武漢、西安、哈爾濱等城市設有辦事處或服務網點。在美國加州的舊金山設有分公司并計劃近期在歐洲開設分公司。 目前，依格斯擁有數百名優秀的員工，是中國國內規模最大的提供臨床研究服務的CRO公司。 依格斯依靠嚴謹勤奮的工作態度、客戶至上的精神、適中的價格贏得了客戶的廣泛信任和業內良好的口碑。


Excel, a leading CRO in China, was founded in Beijing in 1999, and in the last eight years it has grown into a full service CRO providing comprehensive regulatory, clinical research and quality assurance services in the areas of clinical drug development, Phase I~IV, bioequivalence studies, clinical monitoring, project management, patient recruitment, data management, biostatistics analysis, translation, medical report writing and other related services.

Excel's headquarters is located in Beijing, and there are seven satellite offices located throughout China in Shanghai, Guangzhou, Nanjing, Chengdu, Chongqing, Shenyang and Wuhan. Excel has established business offices in the US (San Francisco) and Europe (Cologne, Germany), and has created partnerships with companies in Korea, Taiwan and Australia.

Excel has successfully conducted over 125 clinical trials (phase I to IV) and has obtained nearly 200 regulatory approvals. As one of the few CROs in China using Oracle and SAS for clinical data management and biostatistics analysis, our biometrics services are being developed to comply with US FDA 21 CFR Part 11 requirements.

Our clients currently include many of the top international pharmaceutical companies and many leading biotech companies.